NEOCUTIS technology platform relies on the use of cultured fetal skin cells obtained from a cell bank for treating differing skin conditions. The dedicated cell bank was originally established for wound healing and burn treatments using a single biopsy of donated fetal skin following a one-time medical termination. The cultured cells can be used to produce skin constructs for wound healing or can be incorporated as cell lysate in a topical carrier for use in dermatology and skin care. Having developed a topical preparation for different skin conditions, the use of this preparation for daily skin care became apparent. Today this same cell bank also provides a lasting supply of cells for producing Neocutis’ proprietary skin care ingredient Processed Skin Cell Proteins (PSP®).